Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiolabeled bone-seeking radiopharmaceuticals

H L Atkins1, S C Srivastava

  • 1Medical Department, Brookhaven National Laboratory, Upton, NY 11973, USA.

The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of Conventional and Microwave Sintered Iron Ore Preform.

Materials (Basel, Switzerland)·2022
Same author

Cognitive change and neuroimaging following immunoablative therapy and hematopoietic stem cell transplantation in multiple sclerosis: A pilot study.

Multiple sclerosis and related disorders·2015
Same author

Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity.

Blood cancer journal·2014
Same author

Production of actinomycin-D by the mutant of a new isolate of Streptomyces sindenensis.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]·2013
Same author

Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity.

Blood cancer journal·2013
Same author

Identification of a role for the nuclear receptor EAR-2 in the maintenance of clonogenic status within the leukemia cell hierarchy.

Leukemia·2011
Same journal

The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·2004
Same journal

Imaging cell death in vivo.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·2004
Same journal

Radiolabelled peptides and low molecular weight proteins in metabolic diseases.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·2004
Same journal

"Pathophysiologic mapping" of venous thromboembolism: opportunities for radiolabeled peptides.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·2004
Same journal

Non-oncologic applications of radiolabeled peptides in nuclear medicine.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·2004
Same journal

The role of octreotide scintigraphy in rheumatoid arthritis and sarcoidosis.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·2004
See all related articles

Therapeutic bone-seeking radiopharmaceuticals offer pain relief for bone metastases. This review summarizes available pharmacokinetic data for these important cancer treatment agents, highlighting a need for more research.

Area of Science:

  • Nuclear medicine
  • Radiopharmacology
  • Oncology

Background:

  • Bone-seeking radiopharmaceuticals include diagnostic and therapeutic agents.
  • Therapeutic agents utilize particulate emissions (beta-) and differ from imaging agents.
  • Therapeutic bone seekers are increasingly important for managing pain from osseous metastases.

Purpose of the Study:

  • To review and summarize available pharmacokinetic data for therapeutic bone-seeking radiopharmaceuticals.
  • To address the paucity of published pharmacokinetic information on these agents.
  • To focus specifically on therapeutic agents, excluding single photon bone imaging agents.

Main Methods:

  • Literature review and data summarization.
  • Focus on pharmacokinetic properties of therapeutic bone seekers.

Related Experiment Videos

  • Exclusion of single photon bone imaging agents from the review.

    • Main Results:

    • A review of existing pharmacokinetic data for therapeutic bone-seeking radiopharmaceuticals was conducted.
    • The data highlights a general lack of comprehensive pharmacokinetic information for many agents.
    • The importance of these agents in palliative cancer care is underscored.

    Conclusions:

    • There is a significant need for more research into the pharmacokinetics of therapeutic bone-seeking radiopharmaceuticals.
    • Understanding pharmacokinetics is crucial for optimizing the use of these agents in cancer pain management.
    • This review consolidates current knowledge and identifies gaps in the literature.